F-Star Therapeutics Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 39

Employees

  • Latest Deal Type
  • M&A
  • (Announced)

  • Investors
  • 1

F-Star Therapeutics General Information

Description

Developer of tetravalent bispecific antibodies and immunotherapies designed to support immune modulation in cancer treatment. The company offers patent-protected antibody platforms with dual-targeting capability, enabling individuals with cancer to receive extended treatment benefits and improved disease management.

Contact Information

Website
www.f-star.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • Botanic House, 100 Hills Road
  • Cambridgeshire
  • Cambridge CB2 1PH
  • England, United Kingdom
+44 01223
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Parent Company
invoX Pharma
Corporate Office
  • Botanic House, 100 Hills Road
  • Cambridgeshire
  • Cambridge CB2 1PH
  • England, United Kingdom
+44 01223

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

F-Star Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Merger/Acquisition 02-Apr-2025 Announced Clinical Trials - General
13. Merger/Acquisition 08-Mar-2023 Completed Clinical Trials - General
12. Debt Repayment 01-Mar-2022 Completed Clinical Trials - General
11. Reverse Merger 20-Nov-2020 Completed Clinical Trials - General
10. Merger/Acquisition 28-Oct-2014 Cancelled Clinical Trials - General
9. Accelerator/Incubator Completed Clinical Trials - General
8. Later Stage VC Completed Clinical Trials - General
7. Later Stage VC 23-Oct-2013 Completed Clinical Trials - General
6. Later Stage VC 13-Apr-2011 $21.3M $49.7M Completed Clinical Trials - General
5. Later Stage VC (Series A) 06-Jan-2010 $24.5M $28.4M Completed Startup
To view F-Star Therapeutics’s complete valuation and funding history, request access »

F-Star Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of tetravalent bispecific antibodies and immunotherapies designed to support immune modulation in cancer treat
Drug Discovery
Cambridge, United Kingdom
39 As of 2025

San Diego, CA
 

Zurich, Switzerland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

F-Star Therapeutics Competitors (47)

One of F-Star Therapeutics’s 47 competitors is Crinetics Pharmaceuticals, a Formerly VC-backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Crinetics Pharmaceuticals Formerly VC-backed San Diego, CA
Memo Therapeutics Formerly VC-backed Zurich, Switzerland
Light Chain Bioscience Formerly PE-Backed Geneva, Switzerland
Adaptimmune Therapeutics Formerly VC-backed Abingdon, United Kingdom
Cristal Therapeutics Venture Capital-Backed Maastricht, Netherlands
You’re viewing 5 of 47 competitors. Get the full list »

F-Star Therapeutics Patents

F-Star Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260152558-A1 Multispecific anti-tcr delta variable 1 antibodies Pending 27-Nov-2024
WO-2026115036-A1 Multispecific anti-tcr delta variable 1 antibodies Pending 27-Nov-2024
GB-202304278-D0 Dosage regimens for the administration of a bispecific antibody in combination with chemotherapy Inactive 23-Mar-2023
CA-3208653-A1 Multispecific anti-tcr delta variable 1 antibodies Pending 17-Feb-2022
WO-2023156604-A1 Multispecific anti-tcr delta variable 1 antibodies Inactive 17-Feb-2022 C07K16/2803
To view F-Star Therapeutics’s complete patent history, request access »

F-Star Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

F-Star Therapeutics Former Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Aescap Life Sciences Mutual Fund Minority
Atlas Venture Venture Capital Minority
INiTS Universitäres Gründerservice Accelerator/Incubator Minority
M Ventures Corporate Venture Capital Minority
MP Healthcare Venture Management Corporate Venture Capital Minority
You’re viewing 5 of 11 investors. Get the full list »

F-Star Therapeutics Acquisitions (1)

F-Star Therapeutics’s most recent deal was a Merger/Acquisition with Spring Bank Pharmaceuticals. The deal was made on 20-Nov-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Spring Bank Pharmaceuticals 20-Nov-2024 Merger/Acquisition Drug Discovery
To view F-Star Therapeutics’s complete acquisitions history, request access »

F-Star Therapeutics FAQs

  • When was F-Star Therapeutics founded?

    F-Star Therapeutics was founded in 2002.

  • Where is F-Star Therapeutics headquartered?

    F-Star Therapeutics is headquartered in Cambridge, United Kingdom.

  • What is the size of F-Star Therapeutics?

    F-Star Therapeutics has 39 total employees.

  • What industry is F-Star Therapeutics in?

    F-Star Therapeutics’s primary industry is Drug Discovery.

  • Is F-Star Therapeutics a private or public company?

    F-Star Therapeutics is a Private company.

  • What is F-Star Therapeutics’s current revenue?

    The current revenue for F-Star Therapeutics is .

  • How much funding has F-Star Therapeutics raised over time?

    F-Star Therapeutics has raised $57.5M.

  • Who are F-Star Therapeutics’s investors?

    Aescap Life Sciences, Atlas Venture, INiTS Universitäres Gründerservice, M Ventures, and MP Healthcare Venture Management are 5 of 11 investors who have invested in F-Star Therapeutics.

  • Who are F-Star Therapeutics’s competitors?

    Crinetics Pharmaceuticals, Memo Therapeutics, Light Chain Bioscience, Adaptimmune Therapeutics, and Cristal Therapeutics are some of the 47 competitors of F-Star Therapeutics.

  • When was F-Star Therapeutics acquired?

    F-Star Therapeutics was acquired on 02-Apr-2025.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process